Cited by 115Acute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction

Open access

Bramlage, P, Messer, C, Bitterlich, N, Pohlmann, C, Cuneo, A, Stammwitz, E, Tebbenjohanns, J, Gohlke, H, Senges, J, Tebbe, U·2010·Heart

DOI 10.1136/hrt.2009.188607

Open this paper in CoChat — free account Open PDF

Abstract

Objectives: Five drug classes have been shown to improve the prognosis of acute myocardial infarction in clinical trials: aspirin, β-blockers, statins, renin angiotensin system (RAS) blockers and thienopyridines. We aimed to assess whether the benefits of combining these drugs (termed optimal medical therapy, OMT), will result in a reduction of mortality in clinical practice. Design: Nationwide registry Setting: Hospitals with a cardiology unit or internal medicine department. Patients: 5353 patients with acute myocardial infarction. At hospital discharge 89% received aspirin, 90% β-blockers, 84% statins, 81% RAS blockers, 70% a thienopyridine and 46.2% OMT. Interventions: Pharmacotherapy Main outcome measures: OR with 95% CI for mortality from myocardial infarction were calculated and adjusted for patient risk at baseline. Results: Total mortality was reduced by 74% in patients receiving OMT (adj OR 0.26; 95% CI 0.18 to 0.38) versus patients receiving one or no drug. This was consistent in subgroups defined by STEMI/NSTEMI, diabetes and gender. Mortality was also reduced in patients receiving 2–4 drugs (adj OR 0.49; 95% CI 0.35 to 0.68), diabetic patients being the only subgroup with no significant effect. Analyses on the relative importance of either component revealed that withdrawal of β-blockers (adj OR 0.63; 95% CI 0.34 to 1.16) and/or a combination of aspirin/clopidogrel (adj OR 0.59; 95% CI 0.20 to 1.17) abolished the risk reduction conferred by OMT. Conclusions: OMT over 1 year was associated with a significantly lower mortality of patients with acute myocardial infarction in clinical practice. However OMT is provided to less than half of eligible patients leaving room for substantial improvement.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/hrt.2009.188607

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,475
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Fox, K. A. A., Dabbous, O. H., Goldberg, R. J., Pieper, K. S., Eagle, K. A., de Werf, F. V., Avezum, Á., Goodman, S. G., Flather, M. D., Anderson, F. A., et al. (2006) · BMJ · doi:10.1136/bmj.38985.646481.55 · Cited by 1,699
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Pitt, B., Segal, R., Martínez, F. A., Meurers, G., Cowley, A. J., Thomas, I., DEEDWANIA, P. C., Ney, D. E., Snavely, D. B., & Chang, P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,660
Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article
D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037106.76139.53 · Cited by 844
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial
‡ (2006) · The Lancet · doi:10.1016/s0140-6736(06)68147-6 · Cited by 658
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
Ho, P. M., Spertus, J. A., Masoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Krumholz, H. M., & Rumsfeld, J. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1842 · Cited by 635
Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention
The APEX AMI Investigators (2007) · JAMA · doi:10.1001/jama.297.1.43 · Cited by 447

Show all 31 references

Sorted by citations

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citation
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,435
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 702
Self-citation
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 502
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 319
Self-citation
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
F. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0120 · Cited by 152
Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis
Ma, T., Wong, I. C. K., Man, K. K. C., Chen, Y., Crake, T., Ozkor, M. A., Ding, L., Wang, Z., Zhang, L., & Wei, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210988 · Cited by 101
Long-Term Prognosis of First Myocardial Infarction According to the Electrocardiographic Pattern (ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction and Non-Classified Myocardial Infarction) and Revascularization Procedures
García‐García, C., Subirana, I., Sala, J., Bruguera, J., Sanz, G., Valle, V., Arós, F., Fiol, M., Balaguer, L. M., Serra, J., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.003 · Cited by 79
Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
Ozasa, N., Kimura, T., Morimoto, T., Hou, H., Tamura, T., Shizuta, S., Nakagawa, Y., Furukawa, Y., Hayashi, Y., Nakao, K., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.048 · Cited by 72
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
KONES, R. J. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11100 · Cited by 64
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Kawashima, H., Serruys, P. W. J. C., Ono, M., Hara, H., O’Leary, N., Mack, M. J., Holmes, D. R., Morice, M., Head, S. J., Kappetein, A. P., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.087 · Cited by 61
Excess mortality and guideline-indicated care following non-ST-elevation myocardial infarction
Dondo, T. B., Hall, M., Timmis, A., Gilthorpe, M. S., Alabas, O., Batin, P. D., Deanfield, J. E., Hemingway, H., & Gale, C. P. (2016) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872616647705 · Cited by 45
Optimal combination secondary prevention drug treatment and stroke outcomes
Park, J., & Ovbiagele, B. I. (2014) · Neurology · doi:10.1212/wnl.0000000000001099 · Cited by 41
Optimal Model of Comprehensive Rehabilitation and Secondary Prevention
Jankowski, P., Niewada, M., Bochenek, A. A., Bochenek−Klimczyk, K., Bogucki, M., Drygas, W., Dudek, D., Eysymontt, Z., Grajek, S., Kozierkiewicz, A., et al. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0246 · Cited by 35
Alexithymia: A facet of uncontrolled hypertension
Casagrande, M., Mingarelli, A., Guarino, A., Favieri, F., Boncompagni, I., Germanò, R., Germanò, G., & Forte, G. (2019) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2019.09.006 · Cited by 35
Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)
Antoni, M. L., Hoogslag, G. E., Boden, H., Liem, S., Boersma, E. H., Fox, K. M., Schalij, M. J., Bax, J. J., & Delgado, V. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.029 · Cited by 32
Non-invasive detection of tako-tsubo cardiomyopathy vs. acute anterior myocardial infarction by transthoracic Doppler echocardiography
Meimoun, P., Clerc, J., Vincent, C., Flahaut, F., Germain, A. L., Elmkies, F., Zemir, H., & Luycx-Bore, A. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes192 · Cited by 32
Ischemic heart disease, prescription of optimal medical therapy and geriatric syndromes in community-dwelling older men: A population-based study
Gnjidic, D., Bennett, A., Couteur, D. G. L., Blyth, F., Cumming, R. G., Waite, L. M., Handelsman, D. J., Naganathan, V., Matthews, S. T., & Hilmer, S. N. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.045 · Cited by 30
Medication Use Pattern and Predictors of Optimal Therapy at Discharge in 8176 Patients With Acute Coronary Syndrome From 6 Middle Eastern Countries: Data From the Gulf Registry of Acute Coronary Events
Al-Zakwani, I. S., Zubaid, M., Panduranga, P., Rashed, W. A., Sulaiman, K., Almahmeed, W. A., Al‐Motarreb, A., Suwaidi, J. M. S. A., & Amin, H. (2011) · Angiology · doi:10.1177/0003319710394163 · Cited by 29
Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study
Gunnell, A. S., Einarsdóttir, K., Sanfilippo, F. M., Liew, D., Holman, C. D. J., & Briffa, T. G. (2013) · Heart · doi:10.1136/heartjnl-2013-304348 · Cited by 29
Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry
Amann, U., Kirchberger, I., Heier, M., Golüke, H., von Scheidt, W., Kuch, B., Peters, A., & Meisinger, C. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0688-0 · Cited by 27
Polypill and Global Cardiovascular Health Strategies
Sanz, G., & Fuster, V. (2011) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2011.05.005 · Cited by 27
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry
Ge, Z., Baber, U., Claessen, B. E. P. M., Farhan, S., Chandrasekhar, J., Li, S. X., Sartori, S., Kini, A. S., Rao, S. V., Weiss, S. A., et al. (2018) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.27860 · Cited by 27
Using nationwide ‘big data’ from linked electronic health records to help improve outcomes in cardiovascular diseases: 33 studies using methods from epidemiology, informatics, economics and social science in the ClinicAl disease research using LInked Bespoke studies and Electronic health Records (CALIBER) programme
Hemingway, H., Feder, G. S., Fitzpatrick, N. K., Denaxas, S., Shah, A. D., & Timmis, A. (2017) · Programme Grants for Applied Research · doi:10.3310/pgfar05040 · Cited by 27
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las guías europeas de prevención cardiovascular 2012
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Álvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Revista Española de Salud Pública · doi:10.4321/s1135-57272013000200002 · Cited by 27
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Álvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2013.04.003 · Cited by 26
Exercise as the master polypill of the 21st century for the prevention of cardiovascular disease
Sanchis‐Gomar, F., Fiuza‐Luces, C., & Lucía, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.048 · Cited by 23
Cardiac rehabilitation after acute coronary syndrome comparing adherence and risk factor modification in a community-based shared care model versus hospital-based care in a randomised controlled trial with 12 months of follow-up
Bertelsen, J. B., Refsgaard, J. C., Kanstrup, H., Johnsen, S. P., Qvist, I., Christensen, B., & Christensen, K. L. (2016) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515116666781 · Cited by 22
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study
Resor, C. D., Nathan, A. S., Kereiakes, D. J., Yeh, R. W., Massaro, J. M., Cutlip, D. E., Steg, P. G., Hsieh, W.-H., & Mauri, L. (2016) · Circulation · doi:10.1161/circulationaha.116.024531 · Cited by 21
Short and long term prognosis of patients with myocardial infarction. Hungarian Myocardial Infarction Registry
Jánosi, A., Ofner, P., Merkely, B. P., Polgár, P., Zámolyi, K., Kiss, R. G., Edes, I. F., Csapó, K., Nagy, L., Lupkovics, G., et al. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29679 · Cited by 21
Sex differences in optimal medical therapy following myocardial infarction according to left ventricular ejection fraction
Hay, M., Stehli, J., Martin, C., Brennan, A., Dinh, D. T., Lefkovits, J., & Zaman, S. J. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319900875 · Cited by 21
The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension
Her, A., Choi, B. G., Rha, S., Kim, Y. H., Choi, C. U., & Jeong, M. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242314 · Cited by 20
β-Blocker Therapy in the Era of Primary Percutaneous Intervention for ST Elevation Myocardial Infarction
Lee, Y.-H., Park, J., Tahk, S., Hwang, G., Yoon, M., Choi, S., Choi, B., Lim, H., Yang, H., Seo, K., et al. (2015) · Cardiology · doi:10.1159/000431077 · Cited by 20
Evidence‐based prescribing of drugs for secondary prevention of acute coronary syndrome in A boriginal and non‐ A boriginal patients admitted to W estern A ustralian hospitals
Gausia, K., Katzenellenbogen, J. M., Sanfilippo, F. M., Knuiman, M. W., Thompson, P. L., Hobbs, M., & Thompson, S. (2014) · Internal Medicine Journal · doi:10.1111/imj.12375 · Cited by 20
Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: Results from the antiplatelet treatment observational registries (APTOR)
Zeymer, U., Berkenboom, G. M., Coufal, Z., Belger, M. A., Sartral, M., Norrbacka, K., & Bakhai, A. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.057 · Cited by 19
Effective universal health coverage and improved 1-year survival after acute myocardial infarction: the Chilean experience
Carolina Nazzal, N., Frenz, P., Alonso, F. T., & Lanas, F. T. (2015) · Health Policy and Planning · doi:10.1093/heapol/czv120 · Cited by 19
An Assessment of the Concentration-Related Prognostic Value of Cardiac Troponin I Following Acute Coronary Syndrome
Gale, C. P., Metcalfe, E., West, R. M., Das, R., Kilcullen, N. M., Morrell, C., Crook, R. E., Batin, P. D., Hall, A. S., & Barth, J. H. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.041 · Cited by 18
Evidence‐Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
Lee, K., Han, S., Lee, M., Kim, D., Kwon, J.-B., Park, G., & Park, M. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.121.024370 · Cited by 17
Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction
Chrischilles, E. A., Schneider, K. M., Schroeder, M. C., Letuchy, E. M., Wallace, R. B., Robinson, J. G., & Brooks, J. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13953 · Cited by 17
Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
Looi, K. L., Chow, K. L., Looi, J., Lee, M., Halliday, S., White, H. D., & Ellis, C. (2011) · PubMed · Cited by 16
Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack
Jabri, A. M., Assad, H., & Al‐Jumaili, A. A. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.02.009 · Cited by 16
Unplanned 30-Day Readmission after Coronary Artery Bypass in Patients with Acute Myocardial Infarction
Case, R., George, J., Li, Q., Arnaoutakis, G. J., & Keeley, E. C. (2019) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2019.08.005 · Cited by 15
Secondary Prevention Medication After Myocardial Infarction: Persistence in Elderly People over the Course of 1 Year
Al-Khadra, S., Meisinger, C., Amann, U., Holle, R., Kuch, B., Seidl, H., & Kirchberger, I. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0189-x · Cited by 15
Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
Zhang, L., Shi, J., Pan, Y., Li, Z., Yan, H., Liu, C., Lv, W., Meng, X., & Wang, Y. (2021) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000471 · Cited by 15
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study. IMPACT study
Sotorra‐Figuerola, G., Ouchi, D., Giner‐Soriano, M., & Morros, R. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5261 · Cited by 13
Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
Chen, Y., Tang, X., Gao, R.-L., Yang, Y., Xu, B., & Yuan, J. (2020) · Cardiovascular Therapeutics · doi:10.1155/2020/4351469 · Cited by 12
Secondary prevention: Where we are
Corrà, U., & Piepoli, M. F. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317704978 · Cited by 12
Current discharge management of acute coronary syndromes: data from the Rijnmond Collective Cardiology Research (CCR) study
on behalf of the CCR Study Investigators, Yetgin, T., van der Linden, M. M. J. M., de Vries, A. G., Smits, P. C., van Mechelen, R., Yap, S., Boersma, E. H., Zijlstra, F., & van Geuns, R. (2013) · Netherlands Heart Journal · doi:10.1007/s12471-013-0484-x · Cited by 11
Influence of left ventricular systolic function on the long-term benefit of beta-blockers after ST-segment elevation myocardial infarction
Velásquez‐Rodríguez, J., Bruña, V., Vicent, L., Díez‐Delhoyo, F., Valero‐Masa, M. J., Sousa-Casasnovas, I., Juárez, M., Devesa, C., Fernández‐Avilés, F., & Martínez‐Sellés, M. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2020.07.017 · Cited by 11
Real-life use of the polypill components (ASA+ACEI+statins) after an acute coronary syndrome and long-term mortality
Oliveras, T., Massot, M. F., Abadal, A. C., Rueda, F., Flores, J. S., Carrillo, X., & Bayés‐Genís, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.029 · Cited by 10
A TEN YEAR OVERVIEW OF SURGICAL AND INTERVENTIONAL ARRHYTHMOLOGY IN RUSSIA. SERVICE PECULIAR FEATURES IN THE FAR EAST
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain
Redón, J., Usó, R., Trillo-Mata, J. L., López, C., Morales‐Olivas, F. J., Navarro, J., Sanchís, J. M., Gil, V., & Orozco‐Beltrán, D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.05.071 · Cited by 10
Prevención secundaria post infarto agudo de miocardio en hospitales públicos: implementación y resultados de las garantías GES
Carolina Nazzal, N., Lanas, F. T., Garmendia, M. L., Bugueño, C., Mercadal, E., Eduardo Garcés, S., Yovaniniz, P., & Sanhueza, P. (2013) · Revista médica de Chile · doi:10.4067/s0034-98872013000800003 · Cited by 10
Changes in the baseline characteristics, management and outcomes of acute myocardial infarction in Estonia
Blöndal, M. (2012) · DSpace repository (University of Tartu) · Cited by 10
The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in elderly (≥ 65) patients with acute myocardial infarction without hypertension
Ahn, W. J., Rha, S., Choi, B. G., Jeong, M. H., Ahn, T. H., Yoon, J., Kim, H.-S., Seung, K., Gwon, H., Chae, S. C., et al. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02244-x · Cited by 9
Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
Παπαγεωργίου, Ν., Zacharia, E. M., Briasoulis, Α., Androulakis, E. S., & Tousoulis, D. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.01.001 · Cited by 8
Reducing Health Inequalities: Comparison of Survival After Acute Myocardial Infarction According to Health Provider in Chile
Alonso, F. T., Carolina Nazzal, N., Cerecera, F., & Ojeda, J. I. (2018) · International Journal of Health Services · doi:10.1177/0020731418809851 · Cited by 8
Quality of medical management in coronary artery disease
Shammeri, O. A., Stafford, R. S., Alzenaidi, A., Al-Hutaly, B., & Elmoniem, A. E. A. (2014) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2014.488 · Cited by 7
Implementation of clinical audit to improve adherence to guideline-recommended therapy in acute coronary syndrome
George, N. E., Shukkoor, A. A., Joseph, N., Palanimuthu, R., Kaliappan, T., & Gopalan, R. (2022) · The Egyptian Heart Journal · doi:10.1186/s43044-021-00237-7 · Cited by 7
Selection of percutaneous coronary intervention in elderly patients with acute myocardial infarction in tertiary hospital
Chen, L., Han, L., & Luo, J.-G. (2019) · Medicine · doi:10.1097/md.0000000000016544 · Cited by 6
Impact of controlled blood pressure and pulse rate at discharge on clinical outcomes in patients with ST-segment elevation myocardial infarction
Kobayashi, S., Sakakura, K., Jinnouchi, H., Taniguchi, Y., Tsukui, T., Hatori, M., Watanabe, Y., Yamamoto, K., Seguchi, M., Wada, H., et al. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.09.013 · Cited by 5
Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction
Haraguchi, Y., Sakakura, K., Yamamoto, K., Taniguchi, Y., Tsukui, T., Seguchi, M., Wada, H., Momomura, S., & Fujita, H. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4016-19 · Cited by 5
A new model of secondary prevention of cardiovascular disease in patients after acute coronary syndrome
Pająk, A. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0052 · Cited by 5
Impact of Optimal Medical Therapy on Long-Term Outcomes After Myocardial Revascularization for Multivessel Coronary Disease
Park, J., Kim, S. H., Kim, M., Lee, J., Choi, Y., Kim, H., Kim, T. O., Kang, D., Ahn, J., Yoo, J. Y., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.06.083 · Cited by 4
Impact of Guideline-Directed Drug Therapy after ST-Elevation Myocardial Infarction on Outcome in Young Patients—Age and Sex-Specific Factors
Fischer, A. J., Feld, J., Lange, S. A., Günster, C., Dröge, P., Engelbertz, C. M., Ruhnke, T., Gerß, J., Reinecke, H., & Köppe, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133788 · Cited by 4
Secondary adherence to beta-blockers after ST-elevation myocardial infarction without ventricular dysfunction
López, A. P., Almiñana, M. A., & Peris, J. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.11.012 · Cited by 4
The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study
Zhang, D., Song, X., Raposeiras‐Roubín, S., Abu‐Assi, E., Henriques, J. P. S., D’Ascenzo, F., Saucedo, J., González‐Juanatey, J. R., Wilton, S. B., Kikkert, W. J., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.06.021 · Cited by 4
What to do after cardiac rehabilitation programs: the role of the general practitioner in cardiovascular prevention
Cupples, M., & Heron, N. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2016.755 · Cited by 4
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Alvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Neurología · doi:10.1016/j.nrl.2013.04.011 · Cited by 3
Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology
Knight, C. J., & Timmis, A. (2011) · Heart · doi:10.1136/heartjnl-2011-300979 · Cited by 3
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Alvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.03.003 · Cited by 3
Rehabilitation (EACPR) Developed with the special contribution of the European Association for Cardiovascular Prevention & Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : The Fifth
Vrints, C. J., Wood, D., Zamorano, J. L., Zannad, F. M., Karadeniz, Ş., Mezzani, A., Prescott, E., Ebrahim, S. B. J., Germanò, G., Hobbs, R. F., et al. (2013) · Cited by 3
Self-citation
Impact of diabetes on long-term mortality after presentation with acute myocardial infarction
Gale, C. P., Thow, J. C., Batin, P. D., & Hall, A. S. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328346a710 · Cited by 3
Az akut myocardialis infarctus főbb hazai ellátási jellemzői 2005–2009 között a EuroHOPE kutatás eredményei alapján
Belicza, É., Lám, J., & Kósa, I. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30561 · Cited by 3
The Lessons of COURAGE for the Management of Stable Coronary Artery Disease
Kottke, T. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.047 · Cited by 3
Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction
Zhang, D., Gao, H., Song, X., Raposeiras‐Roubín, S., Abu‐Assi, E., Henriques, J. P. S., D’Ascenzo, F., Saucedo, J., González‐Juanatey, J. R., Wilton, S. B., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110833 · Cited by 2
Sobrecarga oral de glucosa como herramienta para la mejora tras intervencionismo coronario percutáneo
de la Hera, J. M., Delgado, E., Martínez‐Camblor, P., Vegas, J. M., García-Ruiz, J. M., & Lambert, J. L. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.02.023 · Cited by 2
Oral Glucose Tolerance Test as a Tool for Patient Improvement After Percutaneous Coronary Intervention
de la Hera, J. M., Delgado, E., Martínez‐Camblor, P., Vegas, J. M., García-Ruiz, J. M., & Rodríguez‐Lambert, J. L. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.02.022 · Cited by 2
Reasons for Not Meeting Coronary Artery Disease Targets of Care in Ambulatory Practice
Kottke, T. E., Ogwang, Z., & Smith, J. C. (2010) · The Permanente Journal · doi:10.7812/tpp/10-073 · Cited by 2
Impacto pronóstico de la adherencia secundaria a betabloqueantes tras infarto de miocardio con elevación del segmento ST sin disfunción ventricular
López, A. P., Almiñana, M. A., & Peris, J. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2019.11.008 · Cited by 2
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction
Schroeder, M. C., Chapman, C. G., Chrischilles, E. A., Wilwert, J. M., Schneider, K. M., Robinson, J. G., & Brooks, J. M. (2022) · Pharmacy · doi:10.3390/pharmacy10060147 · Cited by 2
Europejskie wytyczne dotycza̧ce zapobiegania chorobom serca i naczyń w praktyce klinicznej na 2012 rok
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Ghent University Academic Bibliography (Ghent University) · Cited by 2
Self-citation
Almanac 2011: Acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology
Knight, C. J., & Timmis, A. (2012) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2012.02.006 · Cited by 2
Temporal Data Mining in Electronic Medical Records from Patients with Acute Coronary Syndrome
Black, W. (2014) · ResearchWorks at the University of Washington (University of Washington) · Cited by 2
Beyond Cholesterol in the Primary Prevention of Cardiovascular Disease: Is The Polypill the Answer?
Sanz, G. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0135-3 · Cited by 1
Coronary artery disease: medical therapy
Ker, J. (2010) · South African Family Practice · doi:10.1080/20786204.2010.10873994 · Cited by 1
Acute coronary syndromes
Knight, C. J., & Timmis, A. (2012) · Srce i krvni sudovi · doi:10.5937/siks1202090k · Cited by 1
The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman
Al-Hadithy, D. A., Al-Maqbali, J. S., Al-Riyami, A. B., Za’abi, M. A., & Al-Zakwani, I. S. (2023) · Pharmacy · doi:10.3390/pharmacy11030079 · Cited by 1
β-blocker therapy after acute myocardial infarction
Tabrizchi, R. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.15 · Cited by 1
Losartan Versus Ramipril on 3-year Clinical Outcomes After Acute Myocardial Infarction in Korean Population: From the Korea Acute Myocardial Infarction Registry-National Institutes of Health
Hyun, S. J., Byun, J. K., Rha, S., Choi, B. G., Choi, S. Y., Cha, J., Jeong, M. H., & the other Korea Acute Myocardial Infarction Registry (KAMIR) investigators (2023) · Journal of Cardiovascular Intervention · doi:10.54912/jci.2023.0008 · Cited by 1
Stellenwert der Lyse im Rettungswesen
Hochreuther, S., Härtel, D., Brockmeier, J., Rohde, M., Machalke, K., Mendrok, H.-C., Bramlage, P., & Tebbe, U. (2013) · Notfall + Rettungsmedizin · doi:10.1007/s10049-013-1727-5 · Cited by 1
Self-citation
Comments on an acute myocardial infarction study
Tormen, W. C., da Rosa, E. M., & Viecceli, C. (2010) · Heart · doi:10.1136/hrt.2010.205674 · Cited by 1
Bundle branch block in ST-elevation myocardial infarction: evidence for action.
Antman, E. M. (2010) · PubMed
Adapatação cultural e avaliação das propriedades de medida da "Self_Efficacy for Appropriate Medication Adherence Scale - SEAMS"
Pedrosa, R. B. D. S. (2014) · doi:10.47749/t/unicamp.2014.932163
La llamada polipill: ¿una solución o un problema?
Álvarez, L., & Sanz, G. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)15010-4
Improved survival of patients with coronary artery disease and low ejection fraction with ICD implantation versus conventional therapy in a real world survey
Aschenbrenner, T., Brockmeier, J., Bramlage, P., Fimmers, R., Cuneo, A., Hochreuther, S., Zemmrich, C., & Tebbe, U. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-382
Self-citation

Authors: Bramlage, P., Messer, C., Bitterlich, N., Pohlmann, C., Cuneo, A., Stammwitz, E., Tebbenjohanns, J., Gohlke, H., Senges, J., & Tebbe, U.
Affiliations: Klinikum Lippe (DE)
Klinikum Lüdenscheid (DE)
Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
Heidelberg University (DE)
Corresponding author: Tebbe, U
ORCID: Bramlage, P
Bitterlich, N
Cuneo, A
Senges, J
Venue: Heart
Publisher: BMJ
Published: 2010-03-29
Volume: 96
Issue: 8
Pages: 604-609
ISSN: 1355-6037 (ISSN-L)
1468-201X
DOI: 10.1136/hrt.2009.188607
OpenAlex: W2162467404
Cited by: 115
References: 31
Citations by year: 2024: 1 · 2023: 9 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 13 · 2015: 4 · 2014: 11 · 2013: 14 · 2012: 15
FWCI: 10.56
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Heart (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: acute myocardial infarction, optimal medical therapy, one-year mortality, aspirin, beta-blockers, statins, renin-angiotensin system inhibitors, thienopyridines, clopidogrel, drug combination therapy, diabetes mellitus, guideline adherence, pharmacotherapy
MeSH terms: Aged, Cardiovascular Agents, Drug Therapy, Combination, Female, Hospitalization, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks